Free Trial

Chemours (CC) Earnings Date, Estimates & Call Transcripts

Chemours logo
$20.89 -0.21 (-1.00%)
(As of 02:29 PM ET)

Chemours Latest Earnings Summary

Actual EPS
(Nov. 4)
$0.40 Beat By $0.08
Consensus EPS
(Nov. 4)
$0.32

Chemours released Q3 2024 earnings on November 4, 2024, reporting an EPS of $0.40, which topped the consensus estimate of $0.32 by $0.08. Quarterly revenue rose .9% year-over-year to $1.50 billion, above the consensus estimate of $1.44 billion. With a trailing EPS of $0.50 and a P/E Ratio of 41.78, Chemours' earnings are expected to grow 57.04% next year, from $1.35 to $2.12 per share.

Get Chemours Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Chemours and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Chemours Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241$0.38$0.38$0.38 
Q2 20241$0.80$0.80$0.80 
Q3 20241$0.38$0.38$0.38 
Q4 20241$0.18$0.18$0.18 
FY 20244$1.74$1.74$1.74 
Q1 20251$0.57$0.57$0.57 
Q2 20251$0.79$0.79$0.79 
Q3 20251$0.61$0.61$0.61 
Q4 20251$0.43$0.43$0.43 
FY 20254$2.40$2.40$2.40 
Q1 20261$0.60$0.60$0.60 
Q2 20261$0.81$0.81$0.81 

Chemours Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/4/2024Q3 2024$0.32$0.40+$0.08$0.98$1.44B$1.50B
8/1/2024Q2 2024$0.57$0.38 -$0.19$0.30$1.53B$1.54B
4/30/2024Q1 2024$0.25$0.32+$0.07$0.30$1.35B$1.35B
3/27/2024Q4 2023$0.29$0.31+$0.02$0.74$1.37B$1.36B
10/26/2023Q3 2023$0.77$0.64 -$0.13$1.15$1.54B$1.49B
7/28/2023Q2 2023$1.09$1.10+$0.01$4.72$1.75B$1.64B
4/28/2023Q1 2023$0.62$0.98+$0.36$1.00$1.46B$1.54B
2/10/2023Q4 2022$0.15$0.08 -$0.07$0.64$1.27B$1.34B

Chemours Earnings - Frequently Asked Questions

Chemours (NYSE:CC) last announced its quarterly earning data on Monday, November 4, 2024. Learn more on CC's earnings history.

In the previous quarter, Chemours (NYSE:CC) reported $0.40 earnings per share (EPS) to beat the analysts' consensus estimate of $0.32 by $0.08. Learn more on analysts' earnings estimate vs. CC's actual earnings.

The conference call for Chemours's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Chemours's latest earnings report can be read online.
Read Transcript

Chemours (NYSE:CC) has a recorded annual revenue of $6.03 billion.

Chemours (NYSE:CC) has a recorded net income of -$238 million. CC has generated $0.50 earnings per share over the last four quarters.

Chemours (NYSE:CC) has a trailing price-to-earnings ratio of 41.78 and a forward price-to-earnings ratio of 15.47.

Chemours's earnings are expected to grow from $1.35 per share to $2.12 per share in the next year, which is a 57.04% increase.

More Earnings Resources from MarketBeat



This page (NYSE:CC) was last updated on 12/6/2024 by MarketBeat.com Staff
From Our Partners